Hellenic journal of nuclear medicine最新文献

筛选
英文 中文
Analysis of the diagnostic value of CT radiomics models in differentiating GIST and other mesenchymal tumors. 分析 CT 放射组学模型在区分 GIST 和其他间质肿瘤方面的诊断价值。
IF 0.9 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-05-01 DOI: 10.1967/s002449912732
Bin Du, Zhihui Zhu, Jin Pu, Yaqin Zhao, Shichao Wang
{"title":"Analysis of the diagnostic value of CT radiomics models in differentiating GIST and other mesenchymal tumors.","authors":"Bin Du, Zhihui Zhu, Jin Pu, Yaqin Zhao, Shichao Wang","doi":"10.1967/s002449912732","DOIUrl":"https://doi.org/10.1967/s002449912732","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the diagnostic value of computed tomography (CT) radiomics models in differentiating gastrointestinal stromal tumors (GIST) and other mesenchymal tumors.</p><p><strong>Material and methods: </strong>A retrospective analysis of clinical data from 153 patients with pathologically confirmed gastrointestinal mesenchymal tumors treated in our hospital from July 2019 to March 2024 was conducted, including 107 cases of GIST, 18 cases of leiomyoma, and 28 cases of schwannoma. LASSO regression was used for feature selection. Logistic regression and Random Forest (RF) models were established based on selected features using machine learning algorithms, with the dataset divided into training (107 cases) and validation sets (46 cases) at a 7:3 ratio. The diagnostic performance of the models was evaluated using receiver operating characteristic (ROC) curves.</p><p><strong>Results: </strong>In the training set, there were significant differences between GIST and non-GIST in terms of enhancement degree, age, maximum diameter, and tumor location distribution (P<0.05). A total of 180 radiomics features were extracted using A.K software. LASSO regression reduced the high-dimensional data to 13 radiomics features. Logistic regression and RF models were established based on these 13 features. The AUC for the Logistic regression model was 0.753 in the training set and 0.582 in the validation set, while the AUC for the RF model was 0.941 in the training set and 0.746 in the validation set. The RF model showed higher diagnostic performance than the Logistic regression model (P<0.05). Decision curve analysis showed that the net benefit of the RF model in differentiating GIST was superior to classifying all patients as either GIST or non-GIST and also superior to the Logistic regression model within a probability threshold range of 20%-90%.</p><p><strong>Conclusion: </strong>The machine learning models based on radiomics features have good diagnostic value in predicting the pathological classification of GIST and other mesenchymal tumors, with the RF model showing superior diagnostic value compared to the Logistic regression model.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142080027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world applicability of differentiated thyroid cancer guidelines. 分化型甲状腺癌指南在现实世界中的适用性。
IF 0.9 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-05-01 DOI: 10.1967/s002449912730
Evanthia Giannoula, Paraskevi Exadaktylou, Christos Melidis, Georgia Koutsouki, Ilias Katsadouros, Agni Tsangaridi, Panos Charalambous, Kyriaki Papadopoulou, Savvas Frangos, Ioannis Iakovou
{"title":"Real-world applicability of differentiated thyroid cancer guidelines.","authors":"Evanthia Giannoula, Paraskevi Exadaktylou, Christos Melidis, Georgia Koutsouki, Ilias Katsadouros, Agni Tsangaridi, Panos Charalambous, Kyriaki Papadopoulou, Savvas Frangos, Ioannis Iakovou","doi":"10.1967/s002449912730","DOIUrl":"https://doi.org/10.1967/s002449912730","url":null,"abstract":"<p><strong>Objective: </strong>Thyroid cancer (TC) is the most common endocrine malignancy with constantly growing incidence. Radioiodine ablation is a safe and effective method for managing TC. Recently various Guidelines (GL) have been published on whom should be ablated, when and under which circumstances. Our study compares 6 GL with a given patient cohort. Additionally, we evaluated each GL's quality via an independent tool.</p><p><strong>Material and methods: </strong>We compared six Guidelines (GL) for TC ablation on a cohort of 336 patients, implementing GL retrospectively: 2009 and 2016 American Thyroid Association (ATA), European Thyroid Association's (ETA) Consensus Statement, UK's National Institute for Health and Care Excellence (NICE), German position paper from Surgery and Nuclear Medicine (German) and European Association of Nuclear Medicine and Society of Nuclear Medicine and Molecular Image (EANM/SNMMI). Quality assessment was conducted using the Appraisal of Guidelines, Research and Evaluation instrument II (AGREE II).</p><p><strong>Results: </strong>Results showed significant variability among GL. American Thyroid Association 2016, a clear improvement of the ATA 2009, presents a large grey area of \"probable ablation candidates\". European Thyroid Association and NICE agree that only a small portion of our ablated patients would benefit from it and the AGREE II tool shows a lack of applicability, but very good scores elsewhere. German and EANM/SNMMI GL agree that most of our clinical decisions to ablate were correct and their AGREE II scores are the highest in all six domains.</p><p><strong>Conclusion: </strong>Considering that dynamic risk classification plays a major role in determining the most appropriate treatment, it appears that the guidelines should be updated in order to support individualized patient management. However, it is the experience of the individual physician that will determine the final decision.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142080029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18F-FDG PET/CT image of NK/T cell lymphoma in the sacroiliac joint. 骶髂关节 NK/T 细胞淋巴瘤的 18F-FDG PET/CT 图像。
IF 0.9 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-05-01 Epub Date: 2024-08-06 DOI: 10.1967/s002449912728
Liu Xiao, Wei Zhang, Lin Li
{"title":"<sup>18</sup>F-FDG PET/CT image of NK/T cell lymphoma in the sacroiliac joint.","authors":"Liu Xiao, Wei Zhang, Lin Li","doi":"10.1967/s002449912728","DOIUrl":"10.1967/s002449912728","url":null,"abstract":"<p><p>NK/T cell lymphoma in the sacroiliac joint is very rare. We reportfluorine-18-fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography/computed tomography (PET/CT) findings of NK/T cell lymphoma in the sacroiliac joint in a 48-year-old man. On <sup>18</sup>F-FDG PET/CT image, it manifested a soft tissue mass with adjacent bone destruction in the sacroiliac joint, which had intense <sup>18</sup>F-FDG uptake. The final pathology supported a diagnosis of NK/T cell lymphoma. Our case added the knowledge of another rare site of NK/T cell lymphoma, which should be regarded as a differential diagnosis for sacroiliac joint mass with intense <sup>18</sup>F-FDG uptake.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pictorial view on false positive findings of 68Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable PSA values. 68Ga-PSMA-11 PET/CT 的假阳性结果及其在前列腺癌根治术后检测不到 PSA 值的患者中的预后价值图解。
IF 1.5 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-04-18 DOI: 10.1967/s002449912702
Z. Dancheva, Sophiya Chausheva, Tanya Stoeva, M. Dyankova, T. Yordanova, B. Chaushev, Rostislav Marinov, Viktor Nikolov, Pavel Abushev, Georgi Todorov, Eleonora Dimitrova, A. Klisarova, Deyan Anakievski
{"title":"A pictorial view on false positive findings of 68Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable PSA values.","authors":"Z. Dancheva, Sophiya Chausheva, Tanya Stoeva, M. Dyankova, T. Yordanova, B. Chaushev, Rostislav Marinov, Viktor Nikolov, Pavel Abushev, Georgi Todorov, Eleonora Dimitrova, A. Klisarova, Deyan Anakievski","doi":"10.1967/s002449912702","DOIUrl":"https://doi.org/10.1967/s002449912702","url":null,"abstract":"OBJECTIVE\u0000Recently, gallium-68-prostate-specific membrane antigen-11 (68Ga-PSMA-11) positron emission tomography/computed tomography (PET/CT) has become a key imaging method in prostate carcinoma staging and biochemical progression, with varying sensitivities in different studies (from 40% to 80%). After four years of experience with 68Ga-PSMA-11 PET/CT, we found that it is possible to detect lesions with increased PSMA expression in patients with undetectable prostate specific antigen (PSA) levels after radical prostatectomy. The key questions we wanted to answer were as follows: if those lesions were malignant and could the early detection of those malignant lesions have a role in patient management? We aimed to identify and follow up PSMA-positive findings for a period of 4 years in patients with prostate cancer after radical prostatectomy and undetectable PSA values at the time of the examination. We also explored false-positive lesions in detail.\u0000\u0000\u0000SUBJECTS AND METHODS\u0000The study included all patients who underwent radical prostatectomy and had undetectable PSA values <0.05ng/mL and who underwent 68Ga-PSMA-11 PET/CT between July 2019 and December 2019. We performed 220 studies and found 40 patients with these characteristics; these patients were included in this study. All of them were followed up until July 2023. Any finding with increased radiopharmaceutical accumulation above the background activity in the respective area was considered a false positive. Prostate-specific membrane antigen accumulation in established lesions was assessed semiquantitatively by the maximum standardized uptake value (SUVmax) and qualitatively by the four-point visual scale proposed in the E-PSMA recommendations.\u0000\u0000\u0000RESULTS\u0000We found 15/40 (37.5%) patients with PSMA-positive findings. These were predominantly bone changes without a corresponding CT abnormality or discrete cystic or osteoblastic lesions with above-background increased PSMA expression. The mean SUVmax of these nonspecific lesions was 3.02 (SD 2.86). After 3.5-4 years of follow-up, biochemical progression was found in only two of the patients.The great sensitivity of the method nowadays is a powerful engine for the development of new therapeutic options. On the other side, the lower specificity due to false positive findings, if misinterpreted, might lead to switching to a higher stage, with the planned radical treatment replaced by palliative treatment.\u0000\u0000\u0000CONCLUSION\u0000The presence of 68Ga-PSMA-11 PET/CT-positive findings in patients after radical prostatectomy and an undetectable PSA had a low predictive value for future progression. The interpretation of 68Ga-PSMA-11 PET/CT should always include a complex assessment of the clinical setting-the risk group, PSA value and degree of PSMA accumulation in the lesions. In these situations, further clarification of PSMA-positive findings is appropriate before deciding to change treatment.","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140687789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Head to head comparison of 68Ga-FAPI PET/CT with 18F-FDG PET/CT in primary and metastatic lesions of gastric tumor: A systematic review and meta-analysis. 68Ga-FAPI PET/CT 与 18F-FDG PET/CT 在胃肿瘤原发和转移病灶中的头对头比较:系统综述和荟萃分析。
IF 1.5 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-04-18 DOI: 10.1967/s002449912703
Cailiang Gao, Huiting Liu, Lirong Zhou, Wei Huang, Xue Liu
{"title":"Head to head comparison of 68Ga-FAPI PET/CT with 18F-FDG PET/CT in primary and metastatic lesions of gastric tumor: A systematic review and meta-analysis.","authors":"Cailiang Gao, Huiting Liu, Lirong Zhou, Wei Huang, Xue Liu","doi":"10.1967/s002449912703","DOIUrl":"https://doi.org/10.1967/s002449912703","url":null,"abstract":"OBJECTIVE\u0000Our study aims to head to head compare the application of gallium-68-fibroblast activation proteininhibitor (68Ga-FAPI) positron emission tomography/computed tomography (PET/CT) and fluorine-18-fluorodeoxyglucose (18F-FDG) PET/CT in primary and metastatic lesions of gastric tumor to determine the superior diagnostic tool.\u0000\u0000\u0000MATERIALS AND METHODS\u0000A systematic search, up to March 31, 2023, across PubMed, Embase, and Cochrane Library databases utilized a data-specific Boolean logic strategy. Sensitivity (SEN) and specificity (SPE) evaluations of 68Ga-FAPI and 18F-FDG PET/CT in gastric cancer lesions were conducted. The quality of the studies was assessed using QUADAS-2, and publication bias was examined through Begg and Egger tests.\u0000\u0000\u0000RESULTS\u0000Analysis involved 141 gastric tumor patients and 2753 metastatic lesions in five studies, with overall satisfactory study quality and no apparent publication bias. Patient-level data showed a combined SEN of 0.95 (95% CI: 0.90-0.98) for 68Ga-FAPI and 0.84 (95% CI: 0.77-0.89) for 18F-FDG. At the lesion level, combined SENs were 0.91 (95% CI: 0.84-0.96) for 68Ga-FAPI and 0.72 (95% CI: 0.63-0.80) for 18F-FDG. The pooled SEN for detecting lymph node metastases was 0.78 (95% CI: 0.74-0.82) for 68Ga-FAPI and 0.35 (95% CI: 0.30-0.39) for 18F-FDG, with pooled SPE values of 0.99 (95% CI: 0.98-0.99) and 0.97 (95% CI: 0.96-0.98), respectively. For detecting distant metastases, pooled SEN values were 0.97 (95% CI: 0.96-0.98) and 0.69 (95% CI: 0.66-0.72) for 68Ga-FAPI and 18F-FDG, with pooled SPE values of 0.86 (95% CI: 0.82-0.89) and 0.64 (95% CI: 0.59-0.68), respectively.\u0000\u0000\u0000CONCLUSION\u0000This meta-analysis concluded that 68Ga-FAPI PET/CT was significantly more sensitive than 18F-FDG PET/CT in assessing primary gastric tumors, lymph nodes, and distant metastases, but the difference in the specificity of lymph node metastasis was not significant.","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140688286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal radionuclide shuntography for device patency: New procedural tips for anuncommon historical technique. 多模式放射性核素分流造影检查装置的通畅性:历史上不常见技术的新程序提示。
IF 1.5 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-04-18 DOI: 10.1967/s002449912705
A. Pisani, D. Rubini, C. Altini, N. Lucarelli, A. Gaudiano, Cristina Ferrari, Giuseppe Rubini
{"title":"Multimodal radionuclide shuntography for device patency: New procedural tips for anuncommon historical technique.","authors":"A. Pisani, D. Rubini, C. Altini, N. Lucarelli, A. Gaudiano, Cristina Ferrari, Giuseppe Rubini","doi":"10.1967/s002449912705","DOIUrl":"https://doi.org/10.1967/s002449912705","url":null,"abstract":"Cerebrospinal fluid (CSF) shunting is an established long-term treatment option for hydrocephalus, and is one of the most commonly performed neurosurgical procedures in western countries.Despite advances in CSF shunt design and management, its failure rates remain high and is most commonly due to obstruction and infection.Cerebrospinal fluidshunt failure diagnosis should be prompt and accurate in establishing timely if its revision is appropriate. Radionuclide shuntography with technetium-99m-diethylenetriaminepetaacetic acid (99mTc-DTPA) is a useful technique for evaluation CSF shunts and management of patients presenting with shunt-related problems, in particular it can avoid unnecessary replacement interventions. Although its execution and interpretation require specific skills, we suggest its execution for the evaluation of device's patency. We here describe the radionuclide shuntography performed with recent hybrid multimodal technologies, with a procedure customized to a complicated patient with hydrocefalus and neoplastic disease. We suggest considering radionuclide shuntography in association with conventional imagingand strongly recommend the additional performance of single photon emission computed tomography/computed tomography (SPECT/CT) because it also provides valuable information to complete the interpretation of planar images.","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140688781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatopulmonary syndrome: Case report of the evidence of intrapulmonary shunt on 99mTc-MAA scintigraphy and contrast transthoracic echocardiography. 肝肺综合征:99mTc-MAA 闪烁层和对比经胸超声心动图显示肺内分流的病例报告。
IF 1.5 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-04-18 DOI: 10.1967/s002449912704
Pingping Zhou, Jun Yang
{"title":"Hepatopulmonary syndrome: Case report of the evidence of intrapulmonary shunt on 99mTc-MAA scintigraphy and contrast transthoracic echocardiography.","authors":"Pingping Zhou, Jun Yang","doi":"10.1967/s002449912704","DOIUrl":"https://doi.org/10.1967/s002449912704","url":null,"abstract":"The hepatopulmonary syndrome (HPS) is characterized by arterial oxygenation defect induced by intrapulmonary vascular dilatations in the setting of liver disease. We report a 57-year-old woman with a history of liver cirrhosis presented with progressive cyanosis, exertional dyspnea and a dry cough. Oxyhemoglobin saturation was 88.5% on room air. Contrast transthoracic echocardiography (cTTE) and technetium-99m-macroaggregated albumin (99mTc-MAA) scintigraphy showed an intrapulmonary shunting and confirmed HPS.","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140686840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Al18F-NOTA-Octreotide outperforms 18F-FDG in identifying rare renal metastases from pancreatic neuroendocrine tumor. Al18F-NOTA-奥曲肽在鉴别胰腺神经内分泌瘤罕见肾转移方面优于18F-FDG。
IF 1.5 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-04-18 DOI: 10.1967/s002449912708
Wei Diao, Zhenyan Ye, Ying Kou, Zhuzhong Cheng
{"title":"Al18F-NOTA-Octreotide outperforms 18F-FDG in identifying rare renal metastases from pancreatic neuroendocrine tumor.","authors":"Wei Diao, Zhenyan Ye, Ying Kou, Zhuzhong Cheng","doi":"10.1967/s002449912708","DOIUrl":"https://doi.org/10.1967/s002449912708","url":null,"abstract":"We presented a case involving a 56-year-old man who had been experiencing shoulder and back pain for over a year, with extensive bone metastases revealed by a bone scan. To identify the primary source of these issues, the patients underwent a fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) scan, which indicated moderate uptake in the right renal soft mass and low uptake in multiple osteolytic lesions. Pathological examination and immunohistochemical staining of the renal mass supported the diagnosis of neuroendocrine tumors. Subsequently, a novel somatostatin receptor imaging agent, Al18F-NOTA-octreotide (18F-OC), was performed to further investigate the source of metastatic lesions and to stage the tumor. The 18F-OC scan revealed a high-uptake lesion in the pancreatic head, as well as additional lymph node and bone metastases lesions.Compared to 18F-FDG, the 18F-OC demonstrated superior imaging capabilities and a significantly higher tumor-to-background ratio in neuroendocrine neoplasms, which contributed to improvingthe staging and treatment management.","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140688560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac involvement in muscular dystrophies: Role of myocardial perfusion imaging. 肌肉萎缩症的心脏受累:心肌灌注成像的作用。
IF 1.5 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-04-18 DOI: 10.1967/s002449912707
Rong Wang, Yongle Wang, Hengyu Yan, Haijun Wang, Ping Xie
{"title":"Cardiac involvement in muscular dystrophies: Role of myocardial perfusion imaging.","authors":"Rong Wang, Yongle Wang, Hengyu Yan, Haijun Wang, Ping Xie","doi":"10.1967/s002449912707","DOIUrl":"https://doi.org/10.1967/s002449912707","url":null,"abstract":"Technetium-99m-methoxy isobutyl isonitrile (99mTc-MIBI) myocardial perfusion imaging (MPI) is a functional imaging method with relatively poor specificity but high sensitivity. Wepresent 48-year-old man with cardiac involvement due to muscular dystrophies (MD). Myocardial perfusion imaging rest images revealed regional myocardial perfusion decrease in multiple walls, enlarged heart and decreased left ventricular systolic function. The lesion location of MPI was consistent with that seen on CMR. Our case showed MPI was useful for detection and evaluation of the MD patient with cardiac involvement. In addition, imaging findings in combination with clinical history and other data are important. The case highlight is thevalue of MPI in myocardiopathy.","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140690201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using haematological indices to predict impaired liver function in DTC patients. 利用血液学指标预测 DTC 患者的肝功能受损情况。
IF 1.5 4区 医学
Hellenic journal of nuclear medicine Pub Date : 2024-04-18 DOI: 10.1967/s002449912700
Yanli Zhou, Hong Chai
{"title":"Using haematological indices to predict impaired liver function in DTC patients.","authors":"Yanli Zhou, Hong Chai","doi":"10.1967/s002449912700","DOIUrl":"https://doi.org/10.1967/s002449912700","url":null,"abstract":"OBJECTIVE\u0000In patients with normal liver function, patients with acute or chronic thyroid disease are more likely to develop liver dysfunction. Although the mechanisms underlying this process are not yet fully understood, it has been shown that hypothyroidism can lead to hepatic injury. We evaluated haematological function trends in patients with differentiated thyroid cancer (DTC) at baseline and approximately 4 weeks after l-thyroxine withdrawal before radioactive iodine ablation.\u0000\u0000\u0000SUBJECTS AND METHODS\u0000This is a retrospective study, and 157 patients were enrolled. Logistic regression analysis was used to find significant predictors. Four weeks after LT4 withdrawal, 64 patients belonged to the group of liver injury, and 93 patients belonged to the group of normal liver function.\u0000\u0000\u0000RESULTS\u0000Univariate analysis determined that platelet count (PC) (P=0.005), mean platelet volume (MPV) (P=0.013), platelet distribution width (PDW) (P=0.039) and absolute lymphocyte count (ALC) (P=0.008) were responsible risk factors for liver injury in DTC patients after withdrawal of levothyroxine (l-thyroxine). Multivariate analysis showed that slight increases in PC (OR: 2.243, P: 0.024) and ALC (OR: 0.398, P: 0.017) were closely associated with liver injury in DTC patients after 4 weeks LT4 withdrawal before radioactive iodine ablation.\u0000\u0000\u0000CONCLUSION\u0000Our results suggest that PC and ALC are independent predictors of hypo-related liver injury. Our study is the first to suggest that haematological indices can be used for predicting the development and progression of hypo-related liver disorders.","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140685882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信